Neurocrine Clinical Site

Kardzhali 7003

1 studies enrolling now · 2 studies all time

What they study most

Major Depressive Disorder, Schizophrenia

Studies at this site

• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia — Completed